REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 25 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $13,000 | -45.8% | 25,500 | 0.0% | 0.00% | -66.7% |
| Q4 2018 | $24,000 | -46.7% | 25,500 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $45,000 | +25.0% | 25,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $36,000 | -7.7% | 25,500 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $39,000 | -25.0% | 25,500 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $52,000 | -16.1% | 25,500 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $62,000 | +106.7% | 25,500 | +142.9% | 0.01% | +100.0% |
| Q2 2017 | $30,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|